AIM IMMUNOTECH INC. (AIM)

Every figure this model derived for AIM, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 0 PaymentsToAcquirePropertyPlantAndEquipment 2024-12-31
cash 9,964,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 10,432,000 AssetsCurrent 2026-06-30
current liabilities 4,946,000 LiabilitiesCurrent 2026-06-30
equity 7,744,000 StockholdersEquity 2026-06-30
interest expense 1,138,000 InterestExpense 2026-06-30
ocf -14,374,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 95,000 Revenues 2026-06-30
sbc 60,000 ShareBasedCompensation 2025-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up AIM on one particular measure came for.

RatioValue
current ratio2.11
current ratio reported2.11
dilution pct189.16
ev owner earnings-0.34
ev sales52.2
interest cover-9.79
revenue growth-21.49
revenue growth per share-72.85
roic-175.21
rule of 40-11745.7
sbc pct revenue63.16

What to be careful about

What this model itself distrusts about AIM's figures. Written by the derivation as it ran, not added afterwards.